Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 24 Feb 2026. The item focuses on Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial. Review the original article for the full source wording and details.
Journal of Clinical Oncology, Volume 44, Issue 11 , Page 959-969, April 2026.